Carestream Dental vs Becton Dickinson
Side-by-side comparison of AI visibility scores, market position, and capabilities
Digital dental imaging and practice management software provider offering intraoral sensors, 3D imaging systems, and clinical software for dental practices and institutions worldwide.
About
Carestream Dental is a Rochester, New York-based provider of dental imaging technology and practice management software, operating as a business unit spun off from Carestream Health. The company offers a comprehensive portfolio of dental imaging solutions spanning intraoral X-ray sensors, panoramic imaging systems, 3D cone beam CT (CBCT) scanners, and the clinical software required to acquire, store, manage, and interpret dental images. Carestream Dental serves general dental practices, specialty clinics, dental schools, and group dental organizations globally.\n\nThe company's imaging software platforms, including CS Imaging and CS PracticeWorks, integrate clinical image management with practice workflow features such as patient scheduling, charting, and treatment planning. This integration between imaging hardware and software creates a vertically integrated ecosystem that encourages multi-product adoption within a single practice. Carestream Dental has built a significant installed base in North America and Europe over several decades of operation as part of larger parent organizations including Kodak and Carestream Health.\n\nCarestream Dental competes in the dental technology market against companies such as Dentsply Sirona, Planmeca, and Patterson Companies. The transition from film-based to digital radiography was a key growth driver historically, and the company now focuses on 3D imaging adoption, digital impression workflow integration, and cloud-connected imaging tools. Its deep roots in imaging hardware combined with proprietary software give it a bundled solution advantage when selling into practices upgrading their full radiography infrastructure.
Franklin Lakes NJ medical technology (NYSE: BDX) at $21.8B FY2025 revenue (+8.2%); $17.5B Reverse Morris Trust spinoff with Waters (2025), Edwards critical care acquisition $4.2B (2024) competing with Baxter for infusion systems.
About
Becton, Dickinson and Company (BD) is a Franklin Lakes, New Jersey-based global medical technology company — publicly traded on the New York Stock Exchange (NYSE: BDX) as an S&P 500 Health Care component — manufacturing and selling medical supplies, devices, laboratory equipment, and diagnostic products through approximately 74,000 employees serving healthcare institutions, clinical laboratories, pharmaceutical companies, and life science researchers in over 190 countries. In fiscal year 2025 (ended September 30, 2025), BD reported full-year revenue of $21.8 billion (up 8.2% year-over-year) with Q4 FY2025 revenue of $5.9 billion (+8.3% reported, +3.9% organic growth), and declared a quarterly dividend of $1.05 per share (+1%). Founded in 1897 in New York City by Maxwell Becton and Fairleigh Dickinson Sr. as a thermometer and surgical instrument maker, BD has grown through 125+ years of acquisitions to become a Fortune 500 ($21.8B revenue, #211 on 2024 Fortune 500) global medtech leader. The company operates through three segments: BD Medical (~50% of revenue, IV catheters, syringes, prefillable drug delivery systems, and medication management solutions), BD Life Sciences (flow cytometry, microbiology, molecular diagnostics, and lab automation), and BD Interventional (advanced patient monitoring, interventional cardiology, and peripheral vascular interventions). BD invests $1.2+ billion annually in R&D. In 2024, BD acquired Edwards Lifesciences' critical care monitoring unit for $4.2 billion.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.